Response to growth hormone in attention deficit hyperactivity disorder: Effects of methylphenidate and pemoline therapy

Pediatrics

Volumn 102, Issue 2 III, 1998, Pages 497-500

  Rao, Jayashree K ^a   Julius, Joanne R ^b   Breen, Timothy J ^b   Blethen, Sandra L ^b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GENENTECH INC   (United States)

Author keywords

Attention deficit hyperactivity disorder; Growth hormone; Idiopathic growth hormone deficiency; Idiopathic short stature; Methylphenidate; Pemoline

Indexed keywords

GROWTH HORMONE; METHYLPHENIDATE; PEMOLINE;

ARTICLE; ATTENTION DEFICIT DISORDER; BODY GROWTH; BODY MASS; CONTROLLED STUDY; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; SEX DIFFERENCE; SHORT STATURE;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; FEMALE; GROWTH; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; MALE; METHYLPHENIDATE; PEMOLINE;

EID: 0031904005     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Stevenson RD, Wolraich ML. Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder. Pediatr Clin North Am. 1989;36:1183-1197
2. Schultz F, Hayford J, Wolraich M, Hintz R, Thompson R. Methylphenidate treatment of hyperactive children: effects on the hypothalamic-pituitary-somatomedin axis. Pediatrics. 1982;70:987-992
3. Greenhill LL, Puig-Antich J, Novacenko H, et al. Prolactin, growth hormone and growth responses in boys with attention deficit disorder and hyperactivity treated with methylphenidate. J Am Acad Child Psychiatry. 1984;23:58-67
4. Spencer T, Biederman J, Wright V, Danon M. Growth deficits in children treated with desipramine: a controlled study. J Am Acad Child Adolesc Psychiatry. 1992;31:235-243
5. Raskin LA, Shaywitz SE, Shaywitz BA, Anderson GM, Cohen DJ. Neurochemical correlates of attention deficit disorder. Pediatr Clin North Am. 1984;31:387-402
6. Martin JB. Neuroendocrine regulation of growth hormone secretion. In: Laron Z, Tikva P, Avis T, eds. Evaluation of Growth Hormone Secretion. Munich, Germany: Otfrid Butenandt; 1983:1-26
7. Kilgore BS, Dickinson LC, Burnett CR, Lee J, Schedwie HK, Elders MJ. Alterations in cartilage metabolism by neurostimulant drugs. J Pediatr. 1979;94:542-554
8. August GP, Lippe BM, Blethen SL, et al. Growth hormone treatment in the United States: demographic and diagnostic features of 2331 children. J Pediatr. 1990;116:899-903
9. Hamill PVV, Drizd TA, Johnson CL, Reed RB, Roche AF, Moore WM. Physical growth: National Center for Health Statistics percentiles. J Clin Endocrinol Metab. 1979;32:607-629
10. Blethen SL, Compton P, Lippe BM, Rosenfeld RG, August GP, Johansson A. Factors predicting the response to growth hormone therapy (GH) in prepubertal children with GH deficiency. J Clin Endocrinol Metab. 1993;76:574-579
11. Burns EC, Tanner JM, Preece MA, Cameron N. Final height and pubertal development in 55 children with idiopathic growth hormone deficiency treated for between 2 and 15 years with human growth hormone. Eur J Pediatr. 1981;137:155-164
12. Joss E, Zuppinger K, Schwarz HP, Roten H. Final height of patients with pituitary growth failure and changes in growth variables after long term hormonal therapy. Pediatr Res. 1983;17:676-679
13. Albertsson-Wikland K, Westphal A, Westergreen U. Daily subcutaneous administration of human growth hormone in growth hormone deficient children. Acta Paediatr Scand. 1986;75:89-97
14. Bourguignon JP, Vandeweghe M, Vanderschueren-Lodeweyckx M, et al. Pubertal growth and final height in hypopituitary boys: a minor role of bone age at onset of puberty. J Clin Endocrinol Metab. 1986;63:376-382
15. Smith PJ, Hindmarsh PC, Brook CGD. Contribution of dose and frequency of administration to the therapeutic effect of growth hormone. Arch Dis Child. 1988;63:491-494
16. Jorgensen JOL. Human growth hormone replacement therapy: pharmacological and clinical aspects. Endocrinol Rev. 1991;12:189-207
17. Jensen J, Garfinkel B. Neuroendocrine aspects of attention deficit hyperactivity disorder. Neurol Clin. 1988;6:111-129